For the quarter ending 2025-12-31, CLX had $60M increase in cash & cash equivalents over the period. $269M in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Net earnings | 161 | 82 | 336 | 191 |
| Depreciation and amortization | 55 | 56 | 57 | 55 |
| Stock-based compensation | 24 | 10 | 17 | 24 |
| Deferred income taxes | 8 | 84 | -2 | 3 |
| Loss on divestiture | 0 | 0 | 0 | 0 |
| Pension settlement charge | - | - | 0 | 0 |
| Goodwill, trademark and other asset impairments | - | - | 0 | - |
| Other | 4 | 12 | 17 | 14 |
| Receivables, net | -38 | -118 | 216 | -7 |
| Inventories, net | 28 | 55 | -117 | 42 |
| Prepaid expenses and other current assets | -11 | 41 | -19 | -11 |
| Accounts payable and accrued liabilities | 34 | -40 | -37 | 51 |
| Operating lease right-of-use assets and liabilities, net | -2 | -2 | 1 | 1 |
| Income taxes payable / prepaid | 14 | -107 | 19 | -1 |
| Net cash provided by operations | 311 | 93 | 294 | 286 |
| Capital expenditures | 42 | 36 | 75 | 53 |
| Proceeds from divestiture, net of cash divested | 0 | 0 | 0 | 0 |
| Other | 1 | -2 | 1 | 0 |
| Net cash (used for) provided by investing activities | -43 | -34 | -76 | -53 |
| Notes and loans payable, net | 89 | 214 | -50 | -134 |
| Treasury stock purchased | 127 | 129 | 75 | 0 |
| Cash dividends paid to clorox stockholders | 151 | 151 | 150 | 150 |
| Cash dividends paid to noncontrolling interests | - | - | 0 | 16 |
| Issuance of common stock for employee stock plans and other | -21 | 7 | -4 | 1 |
| Net cash used for financing activities | -210 | -59 | -279 | -299 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 2 | -1 | 2 | 1 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 60 | -1 | -59 | -65 |
| Cash and cash equivalents at beginning of period | 169 | 170 | 229 | 294 |
| Cash and cash equivalents at end of period | 229 | 169 | 170 | 229 |
CLOROX CO DE (CLX)
CLOROX CO DE (CLX)